Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Hematologic Diseases
×
zanubrutinib
×
Clear all
Filters
3
NCT04662255
2025-05-28
BRUIN-MCL-321
Eli Lilly and Company
Phase 3
Active not recruiting
500 enrolled